Trial Profile
Loteprednol etabonate/tobramycin in infants and children with lid inflammation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Feb 2012
Price :
$35
*
At a glance
- Drugs Loteprednol etabonate/tobramycin (Primary)
- Indications Bacterial infections; Ophthalmic infections
- Focus Adverse reactions
- 01 Apr 2012 Results published in Pediatric Drugs.
- 22 Feb 2012 New trial record